Op-Ed: 12 Ways PBMs Are Helping Patients Access COVID-19 Vaccines

We stand at a promising moment in the course of the COVID-19 pandemic. Vaccines are becoming more widely available as states are opening vaccination appointments to broader categories of a greater number of individuals. Click here to read the full article.

Op-Ed: Pharmacy Benefit Managers – Providing Lower Prescription Drug Costs for State Medicaid Programs Dealing with COVID-19

It’s no secret that the COVID-19 virus’s resultant economic upheaval has left more than 30 million Americans newly unemployed, disrupting access for many to employer-based health insurance at the time they need it the most. Click here to read the full article.

Op-Ed: The Next COVID-19 Challenge – Reduce Employer Rx Costs, Enhance Patient Access

In the coming weeks and months, America will begin attempting to re-start the economy and hopefully take steps toward a semblance of a new normal. Click here to read the full article.

Morning Consult: Pharmacy Benefit Managers: Helping to Keep Americans Healthy During COVID-19

 Our collective will and intellects are being called upon to manage COVID-19, save lives and restore our economy. During this public health emergency, it is crucial that every sector of our health care system steps up to the challenge. America’s pharmacy benefit managers have a key role to play. Click here to read the full article.

Letter to the Editor: Everyone in the pharmacy industry must work together during the COVID-19 pandemic

The recent opinion piece (“PBMs practice prescription drug price gouging during pandemic”) is an inappropriate attack on pharmacy benefit managers (PBMs) in a time when everyone across the health care industry should be coming together for patients. That’s exactly what PBMs are doing: partnering with groups representing doctors, hospitals, insurers and drug manufacturers to work together for patients. Click here to read the full letter.

Letter: Pharmaceutical Supply Chain Stakeholders to Administration

As representatives of the drug supply and payment chain, ranging from pharmaceutical manufacturers, pharmacies, specialty pharmacies, managed care pharmacy, pharmacy benefit managers (PBMs), to health plans, we are aligned on the important principle that the private sector and state and federal governments must work together to facilitate Americans’ reliable access to needed prescription drugs during the COVID-19 pandemic. Click here to read the full letter.

Letter: PCMA Stands with Health Care Industry Against COVID-19

PCMA is partnering with organizations in the health care industry on private and public sector actions to improve health outcomes for all Americans. In a joint letter to Vice President Mike Pence and congressional leaders, organizations representing America’s health care companies outlined actions to help Americans receive the care they need. During this challenging time, all members of the health care community, and the government, should do everything possible to provide our communities with the necessary resources to stay healthy.  Click here to read the full letter.

Letter: PCMA to the Administration’s COVID-19 Task Force

As our nation works tirelessly to address the coronavirus (COVID-19), on behalf of the pharmacy benefit management (PBM) industry, the Pharmaceutical Care Management Association (PCMA) affirms our commitment to support federal, state, and local public health agencies; collaborate with health care providers, first responders, and others; and work closely with American businesses, labor unions, and government programs to ensure working families, seniors, individuals with disabilities, and others get the prescription drugs they need in a timely and cost-effective manner, including at home.  Click here to read the full letter.